Tamam Mohamad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tamam Mohamad has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adam J. Elder
Department of Dermatology, Wayne State University, Detroit, Michigan
1 shared publication - Amer N. Kadri
Divion of Cardiovascular Medicine, Main Line Health, Lankenau Medical Center, Wynnewood, PA 19096, USA
1 shared publication - Eric M. Gnall
Department of Interventional Cardiology, Lankenau Heart Institute, Main Line Health, Wynnewood, PA 19096, USA
1 shared publication - Mahir Elder
School of Medicine, Wayne State University, Detroit, MI 48202, USA
1 shared publication - Mohamad K. Soufi
Division of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX 77550, USA
1 shared publication - Razan Alrawashdeh
Department of Medicine, Faculty of Medicine, University of Jordan, Amman 11942, Jordan
1 shared publication
Latest Publications
- Open Access
- 24 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2468
Mechanical Support in High-Risk Pulmonary Embolism: Review Article
Acute pulmonary embolism (PE) may manifest with mild nonspecific symptoms or progress to a more severe hemodynamic collapse and sudden cardiac arrest. A substantial thrombotic burden can precipitate sudden right ventricular strain and failure. Traditionally, systemic thrombolytics have been employed in such scenarios; however, patients often present with contraindications, or these interventions may prove ineffective. Outcomes for this medically complex patient population are unfavorable, necessitating a compelling argument for advanced therapeutic modalities or alternative approaches. Moreover, patients frequently experience complications beyond hemodynamic instability, such as profound hypoxia and multiorgan failure, necessitating assertive early interventions to avert catastrophic consequences. The existing data on the utilization of mechanical circulatory support (MCS) devices are not exhaustive. Various options for percutaneous MCS devices exist, each possessing distinct advantages and disadvantages. There is an imminent imperative to develop a tailored approach for this high-risk patient cohort to enhance their overall outcomes.
- 24 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (9) , 2468
Open AccessMechanical Support in High-Risk Pulmonary Embolism: Review Article
Acute pulmonary embolism (PE) may manifest with mild nonspecific symptoms or progress to a more severe hemodynamic collapse and sudden cardiac arrest. A substantial thrombotic burden can precipitate sudden right ventricular strain and failure. Traditionally, systemic thrombolytics have been employed in such scenarios; however, patients often present with contraindications, or these interventions may prove ineffective. Outcomes for this medically complex patient population are unfavorable, necessitating a compelling argument for advanced therapeutic modalities or alternative approaches. Moreover, patients frequently experience complications beyond hemodynamic instability, such as profound hypoxia and multiorgan failure, necessitating assertive early interventions to avert catastrophic consequences. The existing data on the utilization of mechanical circulatory support (MCS) devices are not exhaustive. Various options for percutaneous MCS devices exist, each possessing distinct advantages and disadvantages. There is an imminent imperative to develop a tailored approach for this high-risk patient cohort to enhance their overall outcomes.